2/5
07:23 am
sny
Is Sanofi (ENXTPA:SAN) Offering Value After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Is Sanofi (ENXTPA:SAN) Offering Value After Recent Share Price Weakness [Yahoo! Finance]
2/4
01:28 pm
sny
Why OpenAI's drug royalties deal won't work [Yahoo! Finance]
Low
Report
Why OpenAI's drug royalties deal won't work [Yahoo! Finance]
2/3
02:04 pm
sny
Pfizer sets sights on R&D strategy amid modest FY25 results [Yahoo! Finance]
Low
Report
Pfizer sets sights on R&D strategy amid modest FY25 results [Yahoo! Finance]
2/3
01:39 pm
sny
GSK Advances Respiratory And Vaccine Growth With Key RSV And Asthma Moves [Yahoo! Finance]
Low
Report
GSK Advances Respiratory And Vaccine Growth With Key RSV And Asthma Moves [Yahoo! Finance]
2/3
10:06 am
sny
Latent TB Diagnostics Research Report 2026: Global Market Analysis and Forecasts 2025-2029 by Assay, Risk Factor, and Lab/Place with Executive and Consultant Guides [Yahoo! Finance]
Low
Report
Latent TB Diagnostics Research Report 2026: Global Market Analysis and Forecasts 2025-2029 by Assay, Risk Factor, and Lab/Place with Executive and Consultant Guides [Yahoo! Finance]
2/3
08:21 am
sny
Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026 [Yahoo! Finance]
Low
Report
Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026 [Yahoo! Finance]
2/3
08:11 am
sny
Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD) [Yahoo! Finance]
Low
Report
Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD) [Yahoo! Finance]
2/3
02:19 am
sny
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion [Yahoo! Finance]
Low
Report
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion [Yahoo! Finance]
2/3
01:28 am
sny
Sanofi signs share buyback for up to €1B [Seeking Alpha]
Low
Report
Sanofi signs share buyback for up to €1B [Seeking Alpha]
2/3
01:00 am
sny
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
Low
Report
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
2/2
07:52 am
sny
Sanofi Advances Rare Disease And Immunology Pipeline With Multiple Phase 3 Wins [Yahoo! Finance]
Low
Report
Sanofi Advances Rare Disease And Immunology Pipeline With Multiple Phase 3 Wins [Yahoo! Finance]
2/2
01:15 am
sny
Sanofi's genetic disorder drug shows mixed results in late-stage trials [Yahoo! Finance]
Low
Report
Sanofi's genetic disorder drug shows mixed results in late-stage trials [Yahoo! Finance]
2/2
01:13 am
sny
Press Release: Sanofi's venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease [Yahoo! Finance]
Low
Report
Press Release: Sanofi's venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease [Yahoo! Finance]
2/2
01:00 am
sny
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
Low
Report
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
1/31
01:33 am
sny
Low
Report
1/30
07:12 pm
sny
REGN Q4 Earnings Beat Estimates, Sales Rise on Eylea HD Growth [Yahoo! Finance]
Low
Report
REGN Q4 Earnings Beat Estimates, Sales Rise on Eylea HD Growth [Yahoo! Finance]
1/30
07:12 pm
sny
Press Release: Sanofi's Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease [Yahoo! Finance]
Low
Report
Press Release: Sanofi's Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease [Yahoo! Finance]
1/30
09:07 am
sny
Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation [Seeking Alpha]
Low
Report
Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation [Seeking Alpha]
1/30
07:52 am
sny
Regeneron beats quarterly profit estimates on Dupixent strength [Yahoo! Finance Canada]
Low
Report
Regeneron beats quarterly profit estimates on Dupixent strength [Yahoo! Finance Canada]
1/30
07:47 am
sny
Regeneron beats quarterly profit estimates on Dupixent strength [Yahoo! Finance]
Low
Report
Regeneron beats quarterly profit estimates on Dupixent strength [Yahoo! Finance]
1/30
07:16 am
sny
Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds [Seeking Alpha]
Low
Report
Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds [Seeking Alpha]
1/30
07:00 am
sny
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Low
Report
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
1/30
06:51 am
sny
Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook [Seeking Alpha]
Low
Report
Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook [Seeking Alpha]
1/29
04:21 pm
sny
Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... [Yahoo! Finance]
Low
Report
Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... [Yahoo! Finance]
1/29
01:46 pm
sny
AgomAb Therapeutics NV Readies US IPO On Early Promising Results [Seeking Alpha]
Low
Report
AgomAb Therapeutics NV Readies US IPO On Early Promising Results [Seeking Alpha]